12th May, 2021
The United States is considering joint production of Johnson & Johnson's Corona vaccine in India and helping manufacturers such as Serum Institute of India (SII) increase production. Daniel B. Smith, the US Embassy's Charge Affairs Affairs, said this on Tuesday. Smith said the United States was concerned about the current state of the epidemic in India.
The Biden administration stands firmly with India to deal with the crisis. Smith, who was recently acting Foreign Minister and Acting Deputy Foreign Minister, has been appointed Charge Affairs at the US Embassy in India. To a question, he said that it takes time to establish joint production.
The US is looking at how it can invest to increase production and how Johnson & Johnson vaccine production in India can help. Smith also talked about the AstraZeneca vaccine being produced in Baltimore, USA. He said, 'AstraZeneca vaccines are being produced at a plant located on the outskirts of Baltimore. But there is a problem with this plant. So far, the Food and Drug Administration (FDA) of the United States has not certified whether these vaccines are available for anyone's use and export. '